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Abstract
Growth charts are essential for monitoring the postnatal growth of preterm infants. The preterm postnatal follow-up study (PPFS) of
the Intergrowth-21st Project provides new growth standards based on a longitudinal study. This study was conducted to investigate
the prevalence of extrautrine growth restriction (EUGR) and the associated factors of EUGR in preterm infants, using the PPFS
charts and the Fenton charts. Data of 1,356 infants with gestational age (GA) less than 28 weeks from the Korean Neonatal Network
were analysed. The prevalence of small for gestational age (SGA) of weight and length was higher with the Intergrowth charts than
with the Fenton charts. EUGR in weight and length was more prevalent when using the Fenton charts. Multivariate analysis showed
that low GA, high birthweight z score, male, treated patent ductus arteriosus (PDA), necrotizing enterocolitis, intraventricular
haemorrhage and duration of parenteral nutrition (PN) were associated with EUGR in weight by the Intergrowth charts. High
birthweight z score, treated PDA and PN duration were associated with EUGR defined by the Fenton charts.
Conclusion: Compared to the Fenton charts, SGA was more defined and EUGR was less prevalent in extremely low gestational
infants, while EUGR defined by the Intergrowth charts categorized infants with adverse clinical courses more elaborately.
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Introduction
Preterm infants are at risk of extrauterine growth restriction
(EUGR) [1], and optimal postnatal growth is important not
only for survival but also for the long-term outcomes of pre-
term infants [2, 3]. Despite recent improvements in the neo-
natal care of preterm infants, EUGR is still prevalent among
premature babies during and after the neonatal intensive care
unit (NICU) stay [4].
Growth charts are essential tools to monitor postnatal
growth of preterm infants. The American Academy of
What is Known:
• Preterm infants are at risk of extrauterine growth restriction (EUGR), although optimal postnatal growth is important for the long-term outcomes.
• Growth charts are essential tools to monitor the postnatal growth of preterm infants.
What is New:
• EUGR of weight and length were less defined with the Intergrowth charts than the Fenton charts.
• EUGR defined by the Intergrowth preterm postnatal follow-up study (PPFS) chart categorized preterm infants with morbidities more elaborately than
the Fenton charts.
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Pediatrics (AAP) recommended that the growth rate of normal
foetuses should be used as a growth standard for preterm
infants. Estimated foetal weight charts based on intrauterine
growth had been used as references for monitoring postnatal
growth [5]. Another type of neonatal chart is based on
birthweight for gestational age (GA) from various sample
sizes ranging from a single hospital sample to a national pop-
ulation. The Fenton growth chart is one of the commonly used
reference charts based on size at birth, developed from the
Babson and Benda graph and several population studies
[6–8]. As it is not based on the longitudinal study, the change
in weight after birth in preterm population was not included in
the data of the Fenton charts.
The Intergrowth-21st Project is a multicentre, multi-eth-
nic, population-based project. Of the five subjects included
in the project, the Preterm Postnatal Follow-up Study
(PPFS), was conducted to produce standards for postnatal
growth in preterm infants as a more appropriate alternative
to existing references based on size-at-birth measurements.
Growth charts were generated based on rigorous and stan-
dardized anthropometric measurements of selected preterm
infants from the original Intergrowth-21st Project [9].
However, the GA of preterm infants included in the PPFS
was moderately preterm, and data for very preterm infants
were obtained from the small sample size.
Based on the inherent conceptual and methodological lim-
itations of these charts, there is currently no ideal growth stan-
dard for monitoring postnatal growth in preterm infants
[10–12]. Significant deviations were found in the calculation
of postnatal growth depending on the reference dataset that
was used [13].
The objective of this study was to compare the prevalence
of EUGR in extremely low GA infants who were registered in
the Korean Neonatal Network (KNN) using the Fenton and
PPFS charts and to investigate factors associated with EUGR
by both charts.
Methods
This is a population-based study of preterm infants who were
registered in the KNN between January 2013 and December
2015. The KNN is a nationwide neonatal network based on a
prospective web-based registry for very low birth weight
(VLBW) infants, which covers more than 70% of the total
number of VLBW infants in Korea [14]. The KNN registry
was approved by the institutional review board, and written
informed consent was obtained from the parents upon enrol-
ment at each participating hospital. The data in the KNN da-
tabase comprises antenatal and perinatal histories, postnatal
morbidities and clinical outcomes that were evaluated during
and after the hospital stay using a standardised electronic case-
report form. Among the registered population, preterm infants
who were born at < 28 weeks of gestation were included.
Infants who were born at < 24 weeks of gestation, had con-
genital anomalies and died or were transferred to other hospi-
tals were excluded. For the Fenton growth charts available
under 50 weeks of postmenstrual age (PMA), those who were
not discharged from the hospital at 50 weeks of PMA were
also excluded from the study.
Gestational age was calculated according to the last men-
strual period. Respiratory distress syndrome (RDS) was de-
fined by radiologic and clinical diagnosis with treatment with
surfactant replacement. Bronchopulmonary dysplasia (BPD)
was defined as the need for supplemental oxygen or ventilator
support at 28 days after birth [15]. Necrotizing enterocolitis
(NEC) was defined according to Bell’s criteria (stage 2 or
higher) [16]. Intraventricular haemorrhage (IVH) was defined
by the Papile criteria, using cranial ultrasonography [17].
Retinopathy of prematurity (ROP) was defined according to
the international classification of ROP [18].
Percentile and z scores of weight, length and head circum-
ference (HC) at birth were calculated using both the Fenton
growth charts and the Intergrowth-21st very preterm size
charts (https://intergrowth21.tghn.org/standards-tools/) [7,
19, 20]. Size at discharge was also calculated using the
Fenton and Intergrowth PPFS charts. Small for gestational
age (SGA) was defined when weight, length and HC were
less than the 10th percentile for GA [21]. The first definition
of EUGR was decreased z scores of weight, length and HC >
1 at discharge compared with z scores at birth [4]. The second
definition of EUGR was weight, length and HC at discharge
below the 10th percentile. The need for approval was waived
by the Institutional Review Board of Seoul National
University Hospital.
Statistical analysis was performed with STATA 12.1
(StataCorp. 2011, College Station, TX, USA). The paired t
test was used to compare z scores according to the different
growth charts at birth and discharge. Cochran’s Q test was
used to compare the prevalence of EUGR in the study pop-
ulation according to the two growth charts. Student’s t test
and Fisher’s exact test were conducted to compare factors
between the EUGR and non-EUGR groups defined by de-
creased z score > 1 at discharge according to the two growth
charts. Multivariate logistic regression analysis for EUGR in
weight defined by decrease z score > 1 was conducted in
each growth chart to determine factors associated with
EUGR. All possible regressions were conducted with covar-
iates based on the p value (p < 0.10) in the univariate anal-
ysis. The variance inflation factor (VIF) was calculated to
treat multicollinearity and covariates with VIF > 10 were
not included in the multiple logistic regression. Goodness
of fit was evaluated by Hosmer-Lemeshow test. Sensitivity
analysis of multivariate linear regressions was performed for
changes in z score of weight as continuous variables and
provided in the supplementary materials.
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Results
Among the 5,922 preterm infants registered in the KNN data-
base during the study period, 2,318 infants with GA < 28
weeks were selected (Fig. 1). Among them, 290 infants who
were born at < 24 weeks of gestation, 59 infants with a con-
genital anomaly and 65 infants who were not discharged until
50 weeks of PMA were excluded. After additional exclusion
of 548 infants who died or were transferred to other hospitals,
1,356 infants remained in the study population.
The GA at birth and PMA at discharge were 26.4 ± 1.1 and
39.9 ± 3.2 weeks (Table 1). Weights at birth and discharge
were 899.6 ± 189.7 and 2824.2 ± 637.3 grams, respectively.
The neonatal morbidities of the study population are provided
in the supplementary materials (Table S2).
SGA ofweight, length and HC at birth weremore prevalent
with the Intergrowth chart (Table 2). z-scores of weight,
length and HC at birth, as well as at discharge, were lower
with Intergrowth charts, except for the weight z score at dis-
charge (Fenton − 1.44 ± 1.21 vs. Intergrowth − 1.03 ± 1.33).
Fig. 1 Selection of study population. GA, gestational age; PMA,
postmenstrual age
Table 1 Perinatal characteristics and body size of study population
Study population
(n = 1,356)
Gestational age (weeks) 26.4 ± 1.1
Birthweight (grams) 899.6 ± 189.7
Birth length (cm) 34.3 ± 2.6
Birth head circumference (cm) 24.1 ± 1.7
Male sex 701 (51.7)
Maternal diabetes mellitus 97 (7.2)
Oligohydramnios 151 (12.3)
Preterm premature rupture of membrane 584 (43.4)
Multiple birth 404 (29.8)
Maternal hypertension 143 (10.6)
Postmenstrual age at discharge (weeks) 39.9 ± 3.2
Weight at discharge (grams) 2824.2 ± 637.3
Length at discharge (cm) 46.1 ± 3.5
Head circumference at discharge (cm) 32.9 ± 2.1
Values are expressed as number (%) or mean ± standard deviation
Table 2 Size at birth and at discharge by the Fenton and Intergrowth
charts
Fenton Intergrowth p value
SGA weight, n (%) 88 (6.4) 109 (8) < 0.001
SGA length, n (%) 92 (7.1) 137 (10.5) < 0.001
SGA HC, n (%) 94 (7.3) 119 (9.3) < 0.001
Birth weight z score 0.22 ± 0.85 0.18 ± 0.93 < 0.001
Birth length z score 0.18 ± 0.97 − 0.3 ± 0.84 < 0.001
Birth HC z score 0.17 ± 1.05 − 0.18 ± 0.9 < 0.001
Discharge weight z score − 1.44 ± 1.21 − 1.03 ± 1.33 < 0.001
Discharge length z score − 1.94 ± 1.46 − 2.1 ± 1.92 < 0.001
Discharge HC z score − 1.25 ± 1.28 − 1.53 ± 1.76 < 0.001
△§ z score weight − 1.67 ± 1.05 − 1.21 ± 1.15 < 0.001
△§.z score length − 2.08 ± 1.26 − 1.76 ± 1.64 < 0.001
△§ z score HC − 1.38 ± 1.33 − 1.31 ± 1.66 < 0.001
Values are expressed as number (%) or mean ± standard deviation. SGA,
small for gestational age;HC, head circumference. § Differences between
values at discharge and at birth
Fig. 2 Prevalence of EUGR according to the growth charts. EUGR of
weight, length andHC by the Fenton and Intergrowth charts when EUGR
was defined as a decrease in z score > 1 at discharge (a) and when EUGR
was defined as body size < 10th percentile at discharge (b). Cochran’s Q
test showed that the p value of all comparison of EUGR between the
Fenton and Intergrowth chart were < 0.001. EUGR, extrauterine growth
restriction
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However, differences in z scores in all body measurements at
discharge from at birth were smaller when the Intergrowth
charts were used.
When EUGR was defined as a decrease in z score by more
than one, the prevalence of EUGR of weight, length and HC
by the Fenton charts were higher than those defined by the
Intergrowth charts (Fig. 2). EUGR defined by less than the
10th percentile at discharge of weight and length by the
Fenton charts also were higher than those defined by the
Intergrowth charts. However, EUGR of HC by the Fenton
charts was less prevalent than that of the Intergrowth charts.
Infants with EUGR defined as decreased z score > 1 ac-
cording to the Intergrowth charts had lower GA (26.6 ± 1.0 vs.
26.2 ± 1.0 weeks, p < 0.001) and higher birthweight z score
(0.0 ± 1.1 vs. 0.3 ± 0.8, p < 0.001) than with infants with non-
EUGR (Table 3). Male sex, RDS, treated PDA, IVH grade ≥
3, NEC, ROP stage ≥ 2 and sepsis were more prevalent in the
EUGR group.
When EUGR was defined as decreased z core > 1 by
the Fenton charts, GA was lower (26.6 ± 1.1 vs. 26.3 ±
1.0 weeks, p < 0.001) and birthweight z score was
higher in the EUGR group (− 0.1 ± 1.0 vs. 0.3 ± 0.9,
p < 0.001) (Table 4). There were more cases of mater-
nal hypertension in the non-EUGR group. RDS, treated
PDA, IVH, NEC and ROP were more prevalent in the
EUGR group.
Multivariate logistic regression was conducted to find as-
sociated factors with EUGR. When EUGR was defined by
decreased z score > 1 based on the Intergrowth charts, lower
GA, higher birthweight z-score, male sex, high grade IVH,
NEC and longer duration of parenteral nutrition (PN) were
associated with EUGR (goodness of fit, p = 0.426)
(Table 5). When the same definition of EUGR was made by
the Fenton charts, higher birthweight z score, treated PDA,
and longer duration of PNwere associated with EUGR (good-
ness of fit, p = 0.286).
Table 3 Clinical characteristics
of study population by EUGR in
weight based on the Intergrowth
charts
Non-EUGR (n = 612) EUGR
(n = 755)
p value
Gestational age (weeks) 26.6 ± 1.0 26.2 ± 1.0 < 0.001
Birthweight (grams) 891 ± 201.1 908.7 ± 178.9 0.087
Birthweight z score 0.0 ± 1.1 0.3 ± 0.8 < 0.001
Male sex 275 (45.2) 426 (57.0) < 0.001
Caesarean section 428 (70.3) 532 (71.2) 0.719
Maternal diabetes mellitus 49 (8.1) 48 (6.4) 0.289
Chorioamnionitis 240 (44.9) 285 (46.6) 0.593
PPROM 246 (40.8) 338 (45.6) 0.086
Oligohydramnios 71 (13.0) 80 (11.7) 0.541
Prenatal steroid 488 (81.1) 600 (82.1) 0.541
Multiple birth 184 (30.2) 220 (29.5) 0.766
Hypertension 86 (14.1) 57 (7.6) < 0.001
Apgar score 1 min 4 ± 1.9 3.8 ± 1.7 0.102
Apgar score 5 min 6.3 ± 1.8 6.3 ± 1.7 0.714
RDS 587 (96.4) 736 (98.5) 0.013
Treated PDA 319 (52.4) 461 (61.7) 0.001
Moderate to severe BPD 267 (43.8) 367 (49.1) 0.056
IVH ≥ grade 3 36 (5.9) 105 (14.1) < 0.001
NEC 20 (3.3) 74 (9.9) < 0.001
ROP ≥ stage 2 126 (20.7) 207 (27.8) 0.003
Sepsis 163 (26.8) 249 (33.3) 0.009
Duration of PN (days) 29.5 ± 17.7 41.1 ± 23.0 < 0.001
Length of stay (days) 90.4 ± 23.7 98.7 ± 23.8 < 0.001
Values are expressed as number (%) or mean ± standard deviation. EUGR, extrauterine growth restriction;
PPROM, preterm premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus
arteriosus; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; NEC, necrotizing enterocoli-
tis; ROP, retinopathy of prematurity; PN, parenteral nutrition
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Discussion
The present study explored the prevalence and associated fac-
tors of EUGR in extremely low GA infants. EUGR defined as
a > 1 decrease in z score in weight, length and HC as well as
EUGR defined as <10th percentile at discharge in weight and
length were more prevalent based on the Fenton charts. When
EUGR was defined as a > 1 decrease in z score in weight, the
multivariate analysis showed that lower GA, higher
birthweight z score, male sex, IVH, NEC, and longer duration
of PN were associated with EUGR by the Intergrowth charts,
whereas EUGR by the Fenton charts showed association with
higher birthweight z score, treated PDA and longer duration of
PN.
EUGR is a prevalent phenomenon during NICU stay in
preterm infants. Clark et al. defined EUGR as below the
10th percentile at the time of discharge according to an intra-
uterine growth chart and reported the incidence of EUGR in
weight and length at discharge to be 28% and 34% among
preterm infants born at 23–34 weeks GA [21]. Vermont
Oxford Network study reported that EUGR below the 10th
percentile of weight by the Fenton growth chart occurred in
half of VLBW infants [22]. The definition of EUGR as the
change in z scores also has been used, and a study using the
Fenton chart reported the prevalence of EUGR during NICU
admission in preterm infants born at GA of 22–32 weeks as
47% in 2005 and 38% in 2012 [4, 23]. EUGR defined by the
Fenton chart in the present study seemed higher than those
reports, but the study population was less mature in our study
compared with those in the aforementioned studies.
Studies comparing the Fenton and Intergrowth charts re-
ported that EUGR for weight and length were less prevalent
with the Intergrowth charts, as shown in the current study [24,
25]. To evaluate the appropriateness of the growth charts in
defining EUGR, the comparison of long-term outcomes
should be required, which was not investigated in the previous
studies or in our study either. Rather, noted factors or morbid-
ities associated with growth restriction in preterm infants such
as low GA, IVH and NEC were associated with EUGR when
defined according to the Intergrowth charts, but when defined
by the Fenton charts, although treated PDA was associated
with EUGR, low GA, IVH and NEC were not associated with
EUGR [4, 21]. Linear regression analysis showed that NEC
was associated with decreased weight z score at discharge by
Fenton charts, but more factors were associated with EUGR
when it was defined by the Intergrowth charts (Table S3).
Growth charts based on foetal growth standards or cross-
sectional size-at-birth measurements by GA should be used
prudently because growth in utero and ex utero is not compa-
rable due to different biological processes as well as environ-
mental and nutritional aspects. There have been concerns on
the overestimation of EUGR in preterm infants because efforts
to avoid EUGR such as aggressive nutritional support could
lead to unfavourable outcomes later in life including insulin
resistance [26, 27]. Intergrowth PPFS charts could be better
standards for preterm infants because they were made during
the postnatal period based on regular follow-up of preterm
infants without adverse perinatal factors that could affect post-
natal growth. As a result, the growth centiles in the PPFS
charts were lower across the entire GA range than those in
growth charts based on measurements at birth [9].
There are several limitations to our study. First, as only body
sizes at birth and at discharge were registered in the database,
information on growth patterns such as weight loss during first
few days after birth and body sizes at specified timing (i.e. PMA
Table 4 Clinical characteristics of the study population by EUGR in






Gestational age (weeks) 26.6 ± 1.1 26.3 ± 1.0 < 0.001
Birthweight (grams) 880.2 ± 202.4 908 ± 184 0.017
Birthweight z score − 0.1 ± 1.0 0.3 ± 0.9 < 0.001
Male sex 175 (49.3) 526 (52.6) 0.294
Caesarean section 251 (70.7) 709 (70.8) 0.720
Maternal diabetes mellitus 30 (8.5) 67 (6.7) 0.281
Chorioamnionitis 133 (42.9) 392 (46.9) 0.231
PPROM 157 (44.7) 427 (43.0) 0.573
Oligohydramnios 44 (13.8) 107 (11.8) 0.372
Prenatal steroid 286 (81.7) 802 (81.6) 1.000
Multiple birth 112 (31.6) 292 (29.2) 0.418
Hypertension 56 (15.8) 87 (8.7) < 0.001
Apgar score 1 min 4.0 ± 1.9 3.9 ± 1.7 0.264
Apgar score 5 min 6.3 ± 1.8 6.3 ± 1.7 0.463
RDS 340 (95.8) 983 (98.2) 0.015
Treated PDA 170 (47.9) 610 (60.9) < 0.001
Moderate to severe BPD 170 (47.9) 464 (46.4) 0.621
IVH ≥ grade 3 19 (5.4) 122 (12.2) < 0.001
NEC 14 (3.9) 80 (8.0) 0.010
ROP ≥ stage 2 73 (20.6) 260 (26.0) 0.045
Sepsis 93 (26.2) 319 (31.9) 0.051
Duration of PN (days) 28.1 ± 16.9 38.6 ± 22.4 < 0.001
Length of stay (days) 91.4 ± 23.9 96.2 ± 24.0 0.001
Values are expressed as number (%) or mean ± standard deviation.
EUGR, extrauterine growth restriction; PPROM, preterm premature rup-
ture of membrane; RDS, respiratory distress syndrome; PDA, patent
ductus arteriosus; BPD, bronchopulmonary dysplasia; IVH, intraventric-
ular haemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of
prematurity; PN, parenteral nutrition
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36 weeks) was not provided. Moreover, a quarter of eligible
infants with gestational age < 28 weeks were excluded because
they died or were transferred to other hospitals [24, 25]. The
other limitation was that long-term outcomes of growth and
neurodevelopment were not investigated in the present study.
Even though the prevalence of SGA and EUGR was changed
by new growth charts, the more appropriate charts in extremely
preterm infants could not be determined without long-term out-
comes of the study population. However, this study analysed a
large study population of nationwide registered data of preterm
infants to evaluate the prevalence of EUGR and associated fac-
tors by the Fenton charts and the Intergrowth charts.
Conclusions
EUGR of weight and length were less prevalent with the
Intergrowth charts than with the Fenton charts. More morbid-
ities associated with growth restriction of weight were found
when EUGR is defined by the Intergrowth charts. Despite the
differences between two charts, we cannot conclude that one
tool is better than the other, and further validation of
Intergrowth charts with long-term outcome studies for ex-
tremely low GA infants might be required.
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Table 5 Factors associated with EUGR in weight based on the Intergrowth and Fenton charts
Univariate analysis Multivariate analysis
OR 95% CI p value Adjusted OR§ 95% CI p value VIF
Intergrowth Gestational age (weeks) 0.73 (0.65–0.81) < 0.001 0.84 (0.74–0.95) 0.006 7.440
Birthweight z score 1.50 (1.33–1.70) < 0.001 1.65 (1.35–2.02) < 0.001 2.410
SGA weight 0.33 (0.22–0.50) < 0.001 0.81 (0.41–1.58) 0.537 2.520
Male sex 1.61 (1.30–2.00) < 0.001 1.77 (1.39–2.24) < 0.001 2.110
PPROM 1.21 (0.98–1.51) 0.080 1.04 (0.81–1.33) 0.761 1.890
Maternal hypertension 0.50 (0.35–0.72) < 0.001 0.98 (0.62–1.53) 0.923 1.510
Moderate to severe BPD 1.24 (1.00–1.53) 0.052 0.80 (0.62–1.03) 0.089 2.170
Treated PDA 1.47 (1.18–1.82) 0.001 1.19 (0.93–1.52) 0.176 2.540
IVH ≥ grade 3 2.60 (1.75–3.86) < 0.001 1.78 (1.16–2.74) 0.008 1.170
NEC 3.24 (1.95–5.37) < 0.001 2.01 (1.13–3.56) 0.017 1.170
ROP ≥ stage 2 1.47 (1.14–1.89) 0.003 1.15 (0.85–1.55) 0.371 1.450
Sepsis 1.37 (1.08–1.73) 0.009 0.89 (0.68–1.17) 0.422 1.620
Duration of PN (days) 1.03 (1.02–1.04) < 0.001 1.03 (1.02–1.04) < 0.001 5.050
Fenton Gestational age (weeks) 0.80 (0.71–0.91) < 0.001 0.95 (0.83–1.09) 0.454 5.180
Birthweight z score 1.56 (1.35–1.80) < 0.001 1.86 (1.50–2.32) < 0.001 1.890
SGA weight 0.41 (0.26–0.63) < 0.001 1.10 (0.58–2.06) 0.774 1.780
Maternal hypertension 0.51 (0.35–0.73) < 0.001 0.89 (0.57–1.37) 0.587 1.390
Treated PDA 1.70 (1.33–2.17) < 0.001 1.35 (1.03–1.75) 0.027 2.500
IVH ≥ grade 3 2.45 (1.49–4.04) < 0.001 1.66 (0.98–2.81) 0.062 1.160
NEC 2.12 (1.18–3.78) 0.012 1.24 (0.66–2.33) 0.502 1.170
ROP ≥ stage 2 1.35 (1.01–1.81) 0.044 1.11 (0.80–1.56) 0.527 1.420
Sepsis 1.32 (1.00–1.73) 0.046 0.86 (0.64–1.17) 0.341 1.610
Duration of PN (days) 1.03 (1.02–1.04) < 0.001 1.03 (1.02–1.04) < 0.001 4.740
§Adjusted for factors associated with EUGR by each growth charts (p < 0.10) as shown in the table. EUGR, extrauterine growth restriction; SGA, small
for gestational age; PPROM, preterm premature rupture of membrane; BPD, bronchopulmonary dysplasia; PDA, patent ductus arteriosus; IVH,
intraventricular haemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; PN, parenteral nutrition; VIF, variance inflation factor
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